Medicare Enrolled

Dr. Can Ficicioglu, M.D.

Clinical Genetics (M.D.) Physician · Philadelphia, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
3401 CIVIC CENTER BLVD, Philadelphia, PA 19104
2155903376
Registered in NPPES since 2006
NPI: 1114949617 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ficicioglu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ficicioglu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ficicioglu

Dr. Can Ficicioglu is a clinical genetics physician in Philadelphia, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ficicioglu performed 15 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Ficicioglu received a total of $381,651 from 23 pharmaceutical and/or device companies across 430 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ficicioglu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 15 Medicare services $381,651 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
15
Medicare services
1.0× state median for clinical genetics (m.d.) physician
Not available
Unique patients (not deduplicated)
$140
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
15 $140 $531
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$381,651
Total received (2018-2024)
Avg $54,522/year across 7 years
Top 4% in PA for clinical genetics (m.d.) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
430
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$88,645
2023
$88,550
2022
$36,211
2021
$3,475
2020
$42,287
2019
$51,055
2018
$71,427

Payments by company (2024)

GENZYME CORPORATION
$31,078
Chiesi USA, Inc.
$16,886
ModernaTX, Inc.
$12,871
Travere Therapeutics, Inc.
$9,898
Amgen Inc.
$8,838
PTC Therapeutics, Inc.
$3,588
BioMarin Pharmaceutical Inc.
$2,967
Otsuka Pharmaceutical Development & Commercialization, Inc.
$1,300
RECORDATI_RARE_DISEASES_INC.
$720
BTG International, Inc.
$500
Top 3 companies account for 68.6% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$150,821
Travere Therapeutics, Inc.
$37,301
BioMarin Pharmaceutical Inc.
$36,133
Horizon Therapeutics plc
$31,501
Chiesi USA, Inc.
$26,613
Shire North American Group Inc
$23,031
Takeda Pharmaceuticals U.S.A., Inc.
$22,105
ModernaTX, Inc.
$12,871
SWEDISH ORPHAN BIOVITRUM AB
$9,212
Amgen Inc.
$8,838
PTC Therapeutics, Inc.
$4,948
Horizon Pharma plc
$3,900
Cycle Pharmaceuticals Inc
$3,855
Ultragenyx Pharmaceutical Inc.
$3,200
Swedish Orphan Biovitrum AB
$2,240
Otsuka Pharmaceutical Development & Commercialization, Inc.
$1,300
SANOFI-AVENTIS U.S. LLC
$900
RECORDATI_RARE_DISEASES_INC.
$720
Novo Nordisk Inc
$600
Dr.Reddy's Laboratories,Inc.
$600
BTG International, Inc.
$500
Vertex Pharmaceuticals Incorporated
$392
SOBI, INC
$71
Top 3 companies account for 58.8% of all-time payments
Associated products mentioned in payments ›
ALDURAZYME · BMN 165 · CERDELGA · DISEASE STATE · DOJOLVI · ELAPRASE · ELFABRIO · FABRAZYME · Kuvan · LAMZEDE · LUMIZYME · NO PRODUCT DISCUSSED · Naglazyme · Nityr · ORFADIN · Orfadin · POMPE - DISEASE · Palynziq · RAVICTI · VPRIV · Vimizim · XURIDEN
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a clinical genetics physician in Philadelphia?
Compare clinical genetics physicians in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse clinical genetics physicians nearby

Geographic Context

Clinical genetics physicians in nearby ZIP areas
37
County median income
$60,698
Nearest hospital to ZIP centroid (approximate)
PHILADELPHIA VA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ficicioglu is a clinical cardiology specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ficicioglu experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Ficicioglu performed 15 office visit, established patient, complex (40-54 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ficicioglu receive payments from pharmaceutical companies?
Yes. Dr. Ficicioglu received a total of $381,651 from 23 companies across 430 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ficicioglu's costs compare to other clinical genetics physicians in Philadelphia?
Dr. Ficicioglu's average Medicare payment per service is $140. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ficicioglu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →